Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
4/24/2025
Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
4/22/2025
AZ's Ultomiris for Generalized Myasthenia Gravis in China
4/22/2025
China Approves New Indication of Opdivo for NSCLC
4/22/2025
Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance
4/22/2025
Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...
4/22/2025
Zai Lab's Repotrectinib sNDA Accepted by China NMPA
4/22/2025
Hengrui Initiates Phase I Trial for Novel Obesity siRNA Drug HRS-5817 ...
4/19/2025
Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
4/19/2025
China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
4/19/2025
HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
4/17/2025
Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
4/17/2025
Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
4/17/2025
Eli Lilly's Mirikizumab Advances in China with New Indication Filing
4/17/2025
InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
4/17/2025
BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
4/15/2025
Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
4/15/2025
China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
4/15/2025
Gardasil9 Gains Expanded Approval in China
4/14/2025
Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
4/14/2025
Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
4/11/2025
Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
4/11/2025
China Greenlights First Gene Therapy for Hemophilia B
4/10/2025
XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
4/10/2025
Novartis Files for New Indication of Long-Acting Cholesterol-Lowering ...
4/10/2025
Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
4/10/2025
ArkBio Completes Phase 3 Trial for AK0901 for ADHD in China
4/9/2025
RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
4/9/2025
China Launches Phase I Trial for Nation's First Monkeypox Vaccine
4/8/2025
Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
4/5/2025
Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
Page:
4
/
14
Total number of articles:
409
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit